In this podcast, Heidi Moawad, MD interviews Cesar Ochoa-Lubinoff, MD, MPH, FAAP, about recent encouraging clinical trial results in patients with Angelman syndrome.
Cesar Ochoa-Lubinoff, MD, MPH, FAAP
Advertisement
Articles by Cesar Ochoa-Lubinoff, MD, MPH, FAAP
Advertisement
Latest Updated Articles
Phase 2 Trial for Angelman Syndrome UnderwayPublished: June 25th 2019 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
NRLP3 Inhibitor VTX3232 Well-Tolerated, Improves Parkinson Symptoms in Phase 2a Trial
2
Exploring the Role of Aerobic Exercise in Promoting Remyelination in Multiple Sclerosis: Lindsey Wooliscroft, MD, MS
3
Interim ROSSINI Data Highlight Foslevodopa/Foscarbidopa’s Impact in Advanced Parkinson Disease
4
Targeting CD19+ B Cells With Inebilizumab in Myasthenia Gravis
5
